Lack of resistance-associated mutations in UL54 and UL97 genes of circulating Cytomegalovirus strains isolated in a medical center in Taiwan

Journal of the Formosan Medical Association

Volumn 111, Issue 8, 2012, Pages 456-460

  Shao, Pei Lan ^a   Lu, Meng You ^a   Liau, Yi Jen ^a   Kao, Chuan Liang ^a   Chang, Shu Yuan ^a   Huang, Li Min ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Cytomegalovirus; Ganciclovir; Resistance

Indexed keywords

DNA POLYMERASE; GANCICLOVIR; PROTEIN KINASE;

ANTIVIRAL RESISTANCE; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; GENE; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; NONHUMAN; TAIWAN; UL54 GENE; UL97 GENE; VIRUS ISOLATION; VIRUS RESISTANCE; VIRUS STRAIN;

ANTIVIRAL AGENTS; CYTOMEGALOVIRUS; DNA, VIRAL; DNA-DIRECTED DNA POLYMERASE; DRUG RESISTANCE, VIRAL; GANCICLOVIR; GENETIC MARKERS; HOSPITALS, UNIVERSITY; HUMANS; MUTATION; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); POLYMORPHISM, GENETIC; SEQUENCE ANALYSIS, DNA; TAIWAN; VIRAL PROTEINS;

EID: 84865608589     PISSN: None     EISSN: 09296646     Source Type: Journal    
DOI: 10.1016/j.jfma.2011.08.025     Document Type: Article

References (20)

1. Britt W.J., Alford C.A. Cytomegalovirus 1996, 2493-2534. Lippincott-Raven, Philadelphia. 3rd ed. B.N. Fields, D.M. Knipe, P.M. Howley, R.M. Chanock, M.S. Hirsch, J.L. Melnick (Eds.).
2. Reeves M.B., MacAry P.A., Lehner P.J., Sissons J.G.P., Sinclair J.H. Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers. Proc Natl Acad Sci U S A 2005, 102:4140-4145.
3. Buckner F.S., Pomeroy C. Cytomegalovirus disease of the gastrointestinal tract in patients without AIDS. Clin Infect Dis 1993, 17:644-656.
4. Meyers J.D., Flournoy N., Thomas E.D. Risk factors for cytomegalovirus infection after human marrow transplantation. J Infect Dis 1986, 153:478-488.
5. Schreiber A., Harter G., Schubert A., Bunjes D., Mertens T., Michel D. Antiviral treatment of cytomegalovirus infection and resistant strains. Expert Opin Pharmacother 2009, 10:191-209.
6. Stoeva S., Efferth T. Human cytomegalovirus: drug resistance and new treatment options using natural products. Mol Med Report 2008, 6:781-785.
7. Noble S., Faulds D. Ganciclovir: an update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients. Drugs 1998, 56:115-146.
8. Chou S. Antiviral drug resistance in human cytomegalovirus. Transpl Infect Dis 1999, 1:105-114.
9. Chevillotte M, Ersing I, Mertens T, Einem JV. Differentiation between polymorphisms and resistance associated mutations in the human cytomegalovirus DNA polymerase. Antimicrob Agents Chemother . doi:10.1128/AAC.00259-10.
10. Chevillotte M., von Einem J., Meier B.M., Lin F.M., Kestler H.A., Mertens T. A new tool linking human cytomegalovirus drug resistance mutations to resistance phenotypes. Antiviral Res 2010, 85:318-327.
11. Lurain N.S., Spafford L.E., Thompson K.D. Mutation in the UL97 open reading frame of human cytomegalovirus strains resistant to ganciclovir. J Virol 1994, 68:4427-4431.
12. Michel D., Kramer S., Hohn S., Schaarschmidt P., Wunderlich K., Mertens T. Amino acids of conserved kinase motifs of cytomegalovirus protein UL97 are essential for autophosphorylation. J Virol 1999, 73:8898-8901.
13. Erice A. Resistance of human cytomegalovirus to antiviral drugs. Clin Microbiol Rev 1999, 12:286-297.
14. Baldanti F., Gerna G. Human cytomegalovirus resistance to antiviral drugs: diagnosis, monitoring and clinical impact. J Antimicrob Chemother 2003, 52:324-330.
15. Gilbert C., Boivin G. Human cytomegalovirus resistance to antiviral drugs. Antimicrob Agents Chemother 2005, 49:873-883.
16. Boivin G., Goyette N., Gilbert E., Covington E. Analysis of cytomegalovirus DNA polymerase (UL54) mutations in solid organ transplant patients receiving valganciclovir ganciclovir prophylaxis. J Med Virol 2005, 77:425-429.
17. Weinberg A.D., Jabs A., Chou S., Martin B.K., Lurain N.S., Forman M.S., et al. Mutations conferring foscarnet resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis. J Infect Dis 2003, 187:777-784.
18. Zhou L., Fan J., Zheng S.S., Ma W.H. Prevalence of human cytomegalovirus UL97 D605E mutation in transplant recipients in China. Transpl Proceedings 2006, 38:2926-2928.
19. Ijichi O., Michel D., Mertens T., Miyata K., Eizuru Y. GCV resistance due to the mutation A594P in the cytomegalovirus protein UL97 is partially reconstituted by a second mutation at D605E. Antiviral Res 2002, 53:135-142.
20. Sanchez Puch S.I., Mathet V.L., Porta M., Cuestas M.L., Oubiña J.R., Videla C.M., et al. Single and multiple mutations in the human cytomegalovirus UL97 gene and their relationship to the enzymatic activity of UL97 kinase for ganciclovir phosphorylation. Antiviral Res 2009, 84:194-198.